Farther Finance Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$356K Sell
2,162
-154
-7% -$23.7K ﹤0.01% 1624
2025
Q4
$403K Buy
2,316
+725
+46% +$132K ﹤0.01% 1459
2025
Q3
$229K Buy
1,591
+1,106
+228% +$135K ﹤0.01% 1536
2025
Q2
$48.9K Buy
485
+38
+9% +$2.91K ﹤0.01% 2146
2025
Q1
$32.2K Buy
447
+1
+0.2% +$76 ﹤0.01% 2130
2024
Q4
$30.8K Sell
446
-32
-7% -$2.31K ﹤0.01% 1891
2024
Q3
$34.9K Buy
478
+13
+3% +$959 ﹤0.01% 1830
2024
Q2
$30.9K Buy
465
+150
+48% +$5.82K ﹤0.01% 1604
2024
Q1
$8.42K Hold
315
﹤0.01% 1831
2023
Q4
$9.76K Buy
315
+296
+1,558% +$7.68K ﹤0.01% 1621
2023
Q3
$480 Hold
19
﹤0.01% 2283
2023
Q2
$401 Hold
19
﹤0.01% 2213
2023
Q1
$324 Hold
19
﹤0.01% 2106
2022
Q4
$380 Buy
+19
New +$367 ﹤0.01% 1887

Other funds holding INSM

Farther Finance Advisors's INSM Position: Q1 2026 in Review

Farther Finance Advisors reduced its Insmed (INSM) stake by 6.6% in Q1 2026, selling an estimated $23.7K and leaving 2,162 shares worth $356K. The position accounts for ﹤0.01% of the portfolio, ranked #1624.

Farther Finance Advisors first reported a position in INSM in Q4 2022 and has held it in 14 quarters since. The position peaked at $403K in Q4 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Farther Finance Advisors held 2,162 shares of Insmed worth $356K as of Q1 2026.
  • Farther Finance Advisors sold 154 Insmed shares in Q1 2026, an estimated $23.7K.
  • Insmed made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #1624 holding.
  • Farther Finance Advisors first reported a position in Insmed in Q4 2022 and has held it in 14 quarters since.
  • Farther Finance Advisors's Insmed position peaked at $403K in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.